Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
lilly tirzepatide vials Eli Cuts Price of Zepbound Weight Loss Drug With Single-Dose Novo Nordisk launches obesity volume:5mg clinically studied strains
Novo Nordisk launches obesity drug Wegovy in China - The Business Times
Tirzepatide (a dual GLP-1/GIP agonist) achieves 15-22% weight reduction
clinically studied strains
volume:5mg
This news comes as Zepbound outperformed competitors in a weight-loss study and interest in the drug is increasing
US$ 22.61
US$ 20.37
US$ 22.99
US$ 24.58
US$ 29.89
US$ 27.69
